The effects of high-intensity interval training on NLRP3 inflammasome and monocyte chemokine receptors in individuals with obesity
Question
Does 8 weeks of HIIT change NLRP3 inflammasome-related gene expression and monocyte chemokine receptors in adults with obesity?
Summary
In adults with obesity, 8 weeks of supervised cycling HIIT changed some inflammatory gene-expression markers and triglycerides but did not change body composition. The authors reported good adherence and no lesions during training.
Methodology
- Adults with obesity, BMI 30-40 kg/m2, inactive for at least 6 months.
- 109 participants.
- Cycle ergometer.
- Work intervals: 1-2 minutes.
- Recovery: 3 minutes at 50%-70% HRmax.
- Intensity: 80%-100% HRmax.
- Approximately 22-35 minutes.
- 3 sessions/week.
- 8 weeks.
- Prospective randomized controlled study
- NLRP3 inflammasome markers, Monocyte chemokine receptors, Lipids and glucose, and Body composition were tracked.
Outcomes
Inflammasome markers
CASP-1 and IL-6 decreased; NLRP3, IL-1 beta, and IL-18 did not change; ASC increased.
CASP-1 p=0.04, ASC p<0.0001, IL-6 p<0.0001.
Chemokine receptors
CCR2 and CCR5 increased while CX3CR1 decreased in trained participants.
CCR2 p<0.0001, CCR5 p=0.001, CX3CR1 p=0.007.
Triglycerides
Triglycerides decreased in the trained group.
p=0.009.
Body composition
Percent fat, fat mass, lean mass, and total mass did not change.
Insights
- A progressive 1-2 minute cycling HIIT plan can be used in medically cleared adults with obesity.
- Gene-expression changes should not be marketed as direct clinical benefit.
Limitations
- Diet and supplement intake were not controlled.
- Protein-level and functional immune assays were not performed.
- Predominantly female sample and variable age.
- Body composition did not change.
Safety
- Participants were clinically assessed and certified by a medical team as able to engage in exercise training.
- Training intensity was monitored with heart rate and Borg RPE.
- The authors reported good adherence and stated that HIIT did not promote lesions in volunteers; no numeric attendance or detailed adverse-event table was provided.